N. Dendane et al. / Bioorg. Med. Chem. Lett. 18 (2008) 2540–2543
2543
8. Balakirev, M. Y.; Porte, S.; Vernaz-Gris, M.; Berger, M.;
´
Arie, J.-P.; Fouque, B.; Chatelain, F. Anal. Chem. 2005,
77, 5474.
´
9. Blair, S.; Richmond, K.; Rodesch, M.; Bassetti, M.;
Cerrina, F. Nucleic Acids Res. 2006, 34, e110.
10. Defrancq, E.; Hoang, A.; Vinet, F.; Dumy, P. Bioorg.
Med. Chem. Lett. 2003, 13, 2683.
11. Boncheva, M.; Scheibler, L.; Lincoln, P.; Vogel, H.;
Akerman, B. Langmuir 1999, 15, 4317.
12. Dendane, N.; Hoang, A.; Guillard, L.; Defrancq, E.;
Vinet, F.; Dumy, P. Bioconjugate Chem. 2007, 18, 671.
13. Taylor, S.; Smith, S.; Windle, B.; Guiseppi-Elie, A. Nucleic
Acids Res. 2003, 31, e87.
Figure 2. Scanned images of the oligonucleotides arrayed into the
capillary tube. The arrayed capillary tube was obtained after following
procedure: irradiation at 365 nm in 20% aq pyridine solution for
various time periods; deposition of a 20 lM solution of aldehydic
oligonucleotide in water for 2 min; and hybridization with the
complementary strand labeled with Cy3Ò. Time of irradiation: (a)
5 s, (b) 10 s, (c) 15 s, (d) 20 s, (e) 30 s.
14. Trens, P.;Denoyel, R.;Rouquerol,J. Langmuir1995, 11, 551.
15. Preparation of 1: A solution of 2-(2-nitrophenyl)propyl
chloroformate (2.2 g, 9 mmol) in dioxan (20 mL) was added
drop-wise to a solution of carboxymethoxylamine hydro-
chloride (1 g, 4.6 mmol) in 10% aq Na2CO3 (25 mL) at 0 °C.
The solution was stirred for 3 h in darkness and evaporated
under vacuum. The residue so obtained was re-dissolved in
water and the aqueous layer was washed with Et2O,
acidified with 1 N HCl and extracted from CH2Cl2. The
organic layer was dried over Na2SO4 and solvent removed
under vacuum. The crude product was purified by silica gel
column chromatography using CH2Cl2/methanol (97/3,
v/v) as eluent to obtain compound 2 as white powder (1.2 g,
90%). 2 (1.2 g, 4 mmol) was dissolved in anhydrous CH2Cl2
(15 mL) and dicyclohexylcarbodiimide (0.82 g, 4.4 mmol)
and N-hydroxysuccinimide (0.46 g, 4.4 mmol) were added
to the solution. The reaction mixture was stirred overnight,
filtered and evaporated under vacuum. The crude product 1
was obtained after purification by silica gel column chro-
matography (Eluent: EtOAc) as white powder (1 g, 67%).
16. Characterization data for 2: Mp: 88–90 °C; 1H NMR
(300 MHz, CDCl3): d 1.37 (d, J = 7 Hz, 3H), 3.68 (m, 1H),
4.30 (m, 2H), 4.42 (s, 2H), 7.39 (t, J = 8 Hz, 1H), 7.46 (d,
J = 8 Hz, 1H), 7.56 (t, J = 8 Hz, 1H), 7.75 (t, J = 8 Hz,
1H), 8.25 (br s, 1H), 9.45 (br s, 1H); 13C NMR (75 MHz,
CDCl3): d 17.3 (CH3), 33.1 (CH), 70.4 (CH2), 73.5 (CH2),
124.2 (CH), 127.7 (CH), 128.0 (CH), 132.8 (CH), 136.5
(quat), 150.6 (quat), 158.2 (C@O), 172.0 (C@O). ESIMS
(m/z): 297 (MꢀH)ꢀ. Anal. Calcd for C12H13N2NaO7: C,
45.01; H, 4.09; N, 8.75. Found: C, 45.02; H, 4.29; N, 8.56.
Characterization data for 1: 1H NMR (200 MHz, CDCl3):
d 1.39 (d, J = 6 Hz, 3H), 2.89 (s, 4H), 3.68 (m, 1H), 4.31
(m, 2H), 4.39 (s, 2H), 7.30–7.60 (m, 4H). ESIMS (m/z): 395
(M+H)+.
silane-coated glass. The immobilization protocol
reported herein could be an efficient tool in the design
of ‘labs on a chip’ devices.
Acknowledgments
This work was supported by the ‘Centre National de
la Recherche Scientifique’ (CNRS) and the ‘Commis-
`
sariat a l’Energie Atomique’ (CEA). We are grateful
to NanoBio program for the facilities of the Synthesis
Platform.
References and notes
1. Chee, M.; Yang, R.; Hubbell, E.; Berno, A.; Huang, X. C.;
Stern, D.; Winkler, J.; Lockhart, D. J.; Morris, M. S.;
Fodor, S. P. A. Science 1996, 274, 610.
´
2. Thibault, C.; Le Berre, V.; Casimirius, S.; Trevisiol, E.;
Franc¸ois, J.; Vieu, C. J. Nanobiotechnol. 2005, 3, 1.
3. Beaucage, S. L. Curr. Med. Chem. 2001, 8, 1213.
4. Choithani, J.; Kumar, P.; Gupta, K. C. Anal. Biochem.
2006, 357, 240.
5. Chevolot, Y.; Bouillon, C.; Vidal, S.; Morvan, F.;
Meyer, A.; Cloarec, J.- P.; Jochum, A.; Praly, J.-P.;
Vasseur, J.-J.; Souteyrand, E. Angew. Chem. Int. Ed.
2007, 46, 2398.
6. Olivier, C.; Hot, D.; Huot, L.; Ollivier, N.; El-Mahdi, O.;
Gouyette, C.; Huynh-Dinh, T.; Gras-Masse, H.; Lemoine,
Y.; Melnyk, O. Bioconjugate Chem. 2003, 14, 430.
7. Ligler, F. S.; Breimer, M.; Golden, J. P.; Nivens, D. A.;
Dodson, J. P.; Green, T. M.; Haders, D. P.; Sadik, O. A.
Anal. Chem. 2002, 74, 713.
17. For experimental protocol, see Ref. 12.
18. Forget, D.; Boturyn, D.; Defrancq, E.; Lhomme, J.;
Dumy, P. Chem. Eur. J. 2001, 7, 3976.